GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DBV Technologies SA (XPAR:DBV) » Definitions » Short Ratio

DBV Technologies (XPAR:DBV) Short Ratio


View and export this data going back to 2012. Start your Free Trial

What is DBV Technologies Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


DBV Technologies (XPAR:DBV) Business Description

Traded in Other Exchanges
Address
177-181 avenue Pierre Brossolette, Montrouge, FRA, 92120
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node in order to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

DBV Technologies (XPAR:DBV) Headlines

From GuruFocus

DBV Technologies : Reports First Half 2018 Financial Results

By Marketwired Marketwired 09-07-2018

DBV Technologies to Attend Upcoming Investor Conferences

By Marketwired Marketwired 05-01-2018

DBV Technologies to Attend Upcoming Investor Conferences

By Marketwired Marketwired 06-05-2018